Marc Beer – article recap
Renovia Inc through its CEO Marc Beer has been able to raise 42 million dollars that will help the startup develop new products for pelvic floor disorders. Renovia Inc is a medical technology company that was co-founded by Marc Beer and is based in Boston. Marc Beer Co-founded Renovia with the primary objective of developing diagnostic and therapeutic products that will help combat pelvic floor disorders. Pelvic floor disorder is a condition that affects millions of women across the world. According to research, It is estimated that pelvic floor disorder affects more than 250 million women globally. Urinary incontinence is the conventional type of Pelvic Floor Disorder. Renovia line of products includes the Leva Product that got FDA approval in April 2018.
A couple of companies that have interests in the healthcare sector in the US came together to raise funds that will see Renovia develop four more other therapeutic and diagnostic products that will go a long way in helping treat patients with pelvic floor disorders around the world. The healthcare venture capital firms that came together to support Renovia are the Longwood fund, Perceptive Advisors of New York and Ascension Ventures of Missouri. Renovia targets to develop a new generation of the Leva Product.
Marc Beer Renovia founder and Chief Executive Officer in a statement said that Renovia is delighted to have received the support of the three leading firms in the healthcare industry. The firms share the same vision with Renovia of bettering the lives of women globally through the provision of treatment and diagnosis of pelvic floor disorders. Marc Beer believes that the partnership will lead to more innovation and advancement in technologies giving customers valuable information on new treatment options, provide them with knowledge and greater understanding of the disorder and will eventually lower the healthcare costs.
Marc Beer has decades of experience in biotechnology, pharmaceuticals, diagnostics and devices development and commercialization. Marc in August of 2016 together with Ramon Iglesias, MD and Yolanda Lories co-founded Renovia. At Renovia Marc Beer serves as the Chairman and CEO. Marc is a serial entrepreneur, and before starting Renovia, he in 2000 founded ViaCell (NASDAQ: VIAC). ViaCell is a biotech firm. Marc worked at ViaCell for seven years, and under his leadership, the company that had humble beginnings grew to a robust commercial organization with over 300 employees. In the year 2005 ViaCell went public, and in 2007 Marc sold it to PerkinElmer (NYSE: PKI).
Marc Beer is an alumnus of Miami University (Oxford, OH). Marc has served in various organizations in different capacities. Some of the positions Marc has held include serving as a board member of Erytech Pharma, Vice President of global marketing at Genzyme and Sales and marketing at Abbott Laboratories among others. Learn more : https://renoviainc.com/leadership/